C

Central Pharmaceutical JSC No3
VN:DP3

Watchlist Manager
Central Pharmaceutical JSC No3
VN:DP3
Watchlist
Price: 51 000 VND -0.58% Market Closed
Market Cap: 1.1T VND
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

Revenue
+
3Y
-29%
5Y
-16%
10Y
+112%
Operating Income
+
3Y
-3%
5Y
+15%
10Y
+610%
Net Income
+
3Y
+11%
5Y
+36%
10Y
+1 385%

Earnings Waterfall
Central Pharmaceutical JSC No3

Revenue
422.5B VND
Cost of Revenue
-141.7B VND
Gross Profit
280.8B VND
Operating Expenses
-137.7B VND
Operating Income
143.1B VND
Other Expenses
-14.1B VND
Net Income
129.1B VND

Income Statement
Central Pharmaceutical JSC No3

Rotate your device to view
Income Statement
Currency: VND
Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Interest Expense
4 049
4 059
3 904
3 885
0
2 465
2 772
1 160
1 618
1 344
1 797
1 593
1 522
1 510
1 329
1 280
1 366
1 279
1 165
1 243
1 034
2 020
1 969
1 848
1 702
529
449
498
553
631
733
1 004
1 268
1 520
1 594
1 248
888
0
162
142
0
0
Revenue
189 010
N/A
198 874
+5%
212 098
+7%
229 676
+8%
228 316
-1%
224 750
-2%
236 311
+5%
253 166
+7%
284 811
+12%
320 061
+12%
322 482
+1%
362 693
+12%
391 823
+8%
433 802
+11%
471 177
+9%
450 800
-4%
434 900
-4%
422 450
-3%
410 804
-3%
416 623
+1%
525 425
+26%
501 092
-5%
395 721
-21%
493 394
+25%
384 092
-22%
377 540
-2%
381 077
+1%
410 106
+8%
566 134
+38%
593 435
+5%
485 066
-18%
604 765
+25%
454 348
-25%
437 239
-4%
409 731
-6%
393 686
-4%
395 207
+0%
399 314
+1%
417 485
+5%
405 733
-3%
397 546
-2%
422 549
+6%
Gross Profit
Cost of Revenue
(106 880)
(109 629)
(112 996)
(120 719)
(119 905)
(115 109)
(117 709)
(117 716)
(127 289)
(141 016)
(136 421)
(145 715)
(150 362)
(163 539)
(173 879)
(159 768)
(161 048)
(149 584)
(148 763)
(151 232)
(173 533)
(157 304)
(122 006)
(149 295)
(119 135)
(118 782)
(118 993)
(128 148)
(163 269)
(175 403)
(148 528)
(185 443)
(147 089)
(140 387)
(128 228)
(124 249)
(126 631)
(134 190)
(141 432)
(139 539)
(137 419)
(141 733)
Gross Profit
82 131
N/A
89 246
+9%
99 102
+11%
108 958
+10%
108 411
-1%
109 641
+1%
118 602
+8%
135 451
+14%
157 523
+16%
179 045
+14%
186 061
+4%
216 977
+17%
241 459
+11%
270 263
+12%
297 299
+10%
291 031
-2%
273 851
-6%
272 866
0%
262 041
-4%
265 391
+1%
351 892
+33%
343 788
-2%
273 715
-20%
344 099
+26%
264 957
-23%
258 758
-2%
262 084
+1%
281 958
+8%
402 865
+43%
418 032
+4%
336 538
-19%
419 322
+25%
307 258
-27%
296 852
-3%
281 503
-5%
269 438
-4%
268 576
0%
265 124
-1%
276 054
+4%
266 194
-4%
260 127
-2%
280 817
+8%
Operating Income
Operating Expenses
(62 112)
(69 081)
(76 032)
(81 720)
(78 945)
(83 188)
(88 967)
(104 584)
(123 326)
(138 706)
(138 589)
(160 712)
(146 758)
(156 621)
(194 899)
(185 491)
(170 584)
(171 423)
(159 164)
(160 605)
(225 951)
(218 929)
(140 383)
(188 579)
(142 382)
(145 037)
(151 641)
(164 538)
(258 440)
(270 055)
(208 717)
(264 103)
(182 654)
(169 115)
(144 618)
(133 905)
(134 616)
(128 470)
(139 372)
(127 187)
(117 882)
(137 672)
Selling, General & Administrative
(62 072)
(69 040)
(74 424)
(81 254)
(77 474)
(81 717)
(86 834)
(101 931)
(121 175)
(135 975)
(136 410)
(158 490)
(145 627)
(156 070)
(192 642)
(184 952)
(168 698)
(168 905)
(156 620)
(157 857)
(224 002)
(217 613)
(137 796)
(187 190)
(140 226)
(142 113)
(148 526)
(161 304)
(254 155)
(265 585)
(204 885)
(259 296)
(178 655)
(165 057)
(140 687)
(130 056)
(130 899)
(124 925)
(135 929)
(123 797)
(114 542)
(134 373)
Depreciation & Amortization
0
0
(1 608)
0
0
0
(2 133)
(508)
(1 442)
(2 021)
(2 180)
(2 610)
0
(1 097)
(2 257)
(1 086)
(1 885)
(2 518)
(2 544)
(2 748)
0
0
(2 588)
(1 389)
(2 155)
(2 924)
(3 115)
(3 234)
(4 285)
(4 470)
(3 832)
(4 807)
(3 999)
(4 058)
(3 931)
(3 849)
(3 718)
(3 545)
(3 443)
(3 390)
(3 340)
(3 299)
Other Operating Expenses
(40)
(41)
0
(466)
(1 471)
(1 471)
0
(2 145)
(709)
(710)
0
388
(1 131)
546
0
547
0
0
0
0
(1 949)
(1 316)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Operating Income
20 018
N/A
20 164
+1%
23 070
+14%
27 236
+18%
29 465
+8%
26 452
-10%
29 635
+12%
30 867
+4%
34 197
+11%
40 340
+18%
47 472
+18%
56 267
+19%
94 704
+68%
113 644
+20%
102 400
-10%
105 541
+3%
103 268
-2%
101 444
-2%
102 877
+1%
104 786
+2%
125 941
+20%
124 859
-1%
133 332
+7%
155 521
+17%
122 575
-21%
113 721
-7%
110 442
-3%
117 420
+6%
144 425
+23%
147 977
+2%
127 821
-14%
155 219
+21%
124 604
-20%
127 737
+3%
136 885
+7%
135 533
-1%
133 959
-1%
136 654
+2%
136 682
+0%
139 007
+2%
142 245
+2%
143 145
+1%
Pre-Tax Income
Interest Income Expense
(4 083)
(4 095)
(3 943)
(3 920)
(3 527)
(3 115)
(2 691)
(2 346)
(3 009)
(1 493)
(976)
(789)
348
(813)
(603)
(842)
1 360
2 219
559
2 346
3 579
1 620
9 095
8 902
10 755
12 015
5 920
5 831
4 739
4 841
8 575
10 921
15 942
16 016
19 756
18 412
15 816
16 622
15 168
15 368
17 877
18 636
Non-Reccuring Items
0
0
(41)
0
0
0
(12)
0
0
0
(25)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(2)
0
(8)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
163
0
0
0
Total Other Income
(773)
48
1 842
1 497
1 735
2 778
1 641
1 829
1 546
332
1 668
1 868
2 557
2 877
420
748
(2 802)
(3 343)
139
(1 661)
1 294
1 215
532
929
226
195
125
(626)
(413)
(328)
94
664
901
896
360
356
(261)
(649)
(98)
(177)
40
462
Pre-Tax Income
15 162
N/A
16 117
+6%
20 928
+30%
24 813
+19%
27 673
+12%
26 115
-6%
28 573
+9%
30 349
+6%
32 734
+8%
39 179
+20%
48 138
+23%
57 345
+19%
97 608
+70%
115 708
+19%
102 215
-12%
105 448
+3%
101 818
-3%
100 319
-1%
103 576
+3%
105 471
+2%
130 814
+24%
127 694
-2%
142 960
+12%
165 352
+16%
133 557
-19%
125 931
-6%
116 488
-7%
122 625
+5%
148 751
+21%
152 490
+3%
136 490
-10%
166 805
+22%
141 448
-15%
144 648
+2%
157 003
+9%
154 300
-2%
149 515
-3%
152 627
+2%
151 915
0%
154 198
+2%
160 162
+4%
162 242
+1%
Net Income
Tax Provision
(7 069)
(7 421)
(4 708)
(5 563)
(5 827)
(5 367)
(6 056)
(6 163)
(6 909)
(8 236)
(9 803)
(11 645)
(18 889)
(23 326)
(22 152)
(22 798)
(22 920)
(21 782)
(20 854)
(21 272)
(26 411)
(25 785)
(28 899)
(33 410)
(26 996)
(25 465)
(23 561)
(25 422)
(30 755)
(31 562)
(27 665)
(33 745)
(28 563)
(29 186)
(31 740)
(31 230)
(30 326)
(31 002)
(30 743)
(31 204)
(32 802)
(33 163)
Income from Continuing Operations
8 091
8 695
16 220
19 251
21 848
20 749
22 517
24 187
25 825
30 943
38 335
45 701
78 719
92 382
80 063
82 649
78 899
78 538
82 722
84 199
104 403
101 909
114 061
131 942
106 561
100 467
92 927
97 203
117 997
120 928
108 824
133 059
112 885
115 462
125 263
123 070
119 189
121 626
121 172
122 994
127 360
129 080
Net Income (Common)
8 091
N/A
8 695
+7%
16 220
+87%
19 251
+19%
20 800
+8%
19 701
-5%
21 382
+9%
23 052
+8%
24 459
+6%
28 972
+18%
35 652
+23%
41 707
+17%
71 648
+72%
85 916
+20%
74 459
-13%
76 864
+3%
78 962
+3%
73 040
-7%
76 931
+5%
78 305
+2%
91 709
+17%
94 775
+3%
108 357
+14%
125 345
+16%
106 166
-15%
100 071
-6%
88 281
-12%
92 343
+5%
113 350
+23%
116 282
+3%
103 383
-11%
126 406
+22%
106 336
-16%
108 913
+2%
125 263
+15%
124 282
-1%
119 189
-4%
121 626
+2%
121 172
0%
122 994
+2%
127 360
+4%
129 080
+1%
EPS (Diluted)
1 155.85
N/A
1 449.16
+25%
2 219.86
+53%
2 750.14
+24%
2 971.42
+8%
2 814.42
-5%
3 082.28
+10%
3 293.14
+7%
3 494.14
+6%
4 138.85
+18%
4 879.43
+18%
5 958.14
+22%
8 956
+50%
10 935.91
+22%
8 057.75
-26%
11 170.6
+39%
9 008.77
-19%
11 326.44
+26%
9 409.53
-17%
9 309.8
-1%
10 663.78
+15%
11 020.36
+3%
5 039.88
-54%
14 574.98
+189%
12 344.87
-15%
11 636.22
-6%
4 106.08
-65%
10 737.52
+162%
13 180.27
+23%
5 408.45
-59%
4 808.51
-11%
5 879.36
+22%
4 945.86
-16%
5 065.74
+2%
5 826.22
+15%
5 780.56
-1%
5 543.09
-4%
5 657.64
+2%
5 635.9
0%
5 720.67
+2%
5 923.74
+4%
6 003.72
+1%

See Also

Summary
DP3 intrinsic value, competitors valuation, and company profile.
DCF Valuation
DP3 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DP3 stock valuation using valuation multiples.
Wall Street Estimates
DP3 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DP3 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 303,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.